+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
From
Heparin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Heparin Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Anticoagulants Market Report and Forecast 2023-2031 - Product Thumbnail Image

Anticoagulants Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Heparin Market 2024-2028 - Product Thumbnail Image

Heparin Market 2024-2028

  • Report
  • November 2023
  • 165 Pages
  • Global
From
From
From
From
From
From
Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2020 - Product Thumbnail Image

Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 35 Pages
  • Global
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more